Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment

BACKGROUND: Brain metastases are common in patients with metastatic melanoma. With increasing numbers of melanoma patients on anti-PD-1 therapy, we sought to evaluate the safety and initial response of brain metastases treated with concurrent pembrolizumab and radiation therapy. METHODS: From an ins...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Immunother Cancer
Autors principals: Anderson, Erik S., Postow, Michael A., Wolchok, Jedd D., Young, Robert J., Ballangrud, Åse, Chan, Timothy A., Yamada, Yoshiya, Beal, Kathryn
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5644249/
https://ncbi.nlm.nih.gov/pubmed/29037215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-017-0282-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars